Bradenton, Florida Clinical Trials

A listing of Bradenton, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 205 clinical trials
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Patients With Metastatic Colorectal Cancer

This is a global, randomized, double-blind, placebo-controlled, multicenter phase 3 clinical trial to compare the efficacy and safety of fruquintinib plus best supportive care (BSC) versus placebo plus BSC in patients with refractory metastatic colorectal cancer (mCRC). 687 subjects will be randomized to one of the following treatment arms in …

adenocarcinoma
measurable disease
microsatellite instability high
irinotecan
fluoropyrimidine
Florida Cancer Specialists South
 (6.7 away) Contact site
  • 0 views
  • 30 Apr, 2021
  • +138 other locations
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb

The purpose of this study is to assess safety and efficacy of BAY1817080 compared to elagolix and placebo in women with symptomatic endometriosis. Study details include: Study duration: 155 up to 285 days Treatment duration: 84 days Visit frequency: approximately once a month

elagolix
laparoscopy
ibuprofen
endometriosis
laparotomy
Physician Care Clinical Research
 (7.1 away) Contact site
  • 0 views
  • 03 Jun, 2021
  • +201 other locations
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at …

immunomodulators
remission
tumor necrosis factor
tumour necrosis
crohn's disease
Florida Research Institute
 (6.5 away) Contact site
  • 0 views
  • 31 May, 2021
  • +550 other locations
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well monoclonal antibodies work, either alone or in combination, against the virus that causes COVID-19. Study drug(s) will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much …

Synergy Healthcare LLC
 (7.0 away) Contact site
  • 0 views
  • 21 Jun, 2021
  • +154 other locations
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

The Ischemia-IMT (Ischemia-Intensive Medical Treatment Reduces Events in Women with Non-Obstructive CAD), subtitle: Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR) trial is a multicenter, prospective, randomized, blinded outcome evaluation (PROBE design) evaluating intensive statin/ACE-I (or ARB)/aspirin treatment (IMT) vs. usual care (UC) in 4,422 symptomatic women patients …

angiography
aspirin
chest pain
coronary ct
stroke
Cardiovascular Center of Sarasota
 (7.1 away) Contact site
  • 492 views
  • 03 Feb, 2021
  • +70 other locations
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

This is a Phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy on TVB-2640 in subjects with non-alcoholic steatohepatitis (NASH). Subjects will be randomly assigned toTVB-2640 or matching placebo PO QD for 52 weeks, with the first dose administered on Day 1.

Headlands Research Sarasota
 (3.6 away) Contact site
  • 0 views
  • 05 Jun, 2021
  • +65 other locations
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo (a "dummy" medicine which does not contain any study medicine) - which treatment participants get is decided by an equal chance. The study will …

Novo Nordisk Investigational Site
 (7.1 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +85 other locations
Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

The purpose of this study is to evaluate the effectiveness of ProstAtak immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing tumor cells in an immune stimulatory environment induces the body's immune system to …

external beam radiation therapy
androgens
tumor cells
cancer vaccine
antiandrogen therapy
21st Century Oncology
 (2.6 away) Contact site
  • 1420 views
  • 02 Jun, 2021
  • +78 other locations
ImPACT Normative Extension

The researchers want to find out more about a standalone software application, ImPACT Online and how it relates to other commonly used tests of memory, attention and reaction time. ImPACT Online is a computer-based neurocognitive test for concussion management. The test was designed to help measure the effects of concussion …

Comprehensive Med Psych Systems, Inc.
 (6.7 away) Contact site
  • 326 views
  • 03 Mar, 2021
  • +2 other locations
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

The primary goal of this Phase 1 study is to characterize the safety and tolerability of MGD013 and establish the maximum tolerated dose (MTD) of MGD013. Pharmacokinetics (PK), immunogenicity, pharmacodynamics (PD), and the anti-tumor activity of MGD013 will also be assessed.

erbb2
solid tumour
measurable disease
HER2
cancer
Florida Cancer Specialists & Research Institute
 (5.4 away) Contact site
  • 534 views
  • 17 Feb, 2021
  • +69 other locations